Ascendis Pharma A (ASND) Non-Current Assets (2012 - 2026)

Ascendis Pharma A has disclosed Non-Current Assets across 15 years of filings, most recently posting $1.0 billion for Q1 2026.

• Non-Current Assets for Q1 2026 came in at $1.0 billion, up 600.59% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.0 billion (up 600.59% YoY), and the FY2025 annual result was $225.3 million, down 89.42% from the prior year.
• Non-Current Assets came in at $1.0 billion for Q1 2026 at Ascendis Pharma A, up from $225.3 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $2.1 billion in Q4 2024 to a low of $131.8 million in Q3 2024.
• The 5-year median for Non-Current Assets is $160.1 million (2025), against an average of $339.0 million.
• Across the five-year window, Non-Current Assets soared 1511.55% in 2024 and slumped 89.42% in 2025, its largest moves.
• Ascendis Pharma A's Non-Current Assets stood at $169.6 million in 2022, then decreased by 22.07% to $132.2 million in 2023, then jumped by 1511.55% to $2.1 billion in 2024, then plunged by 89.42% to $225.3 million in 2025, then jumped by 357.69% to $1.0 billion in 2026.
• The last three Non-Current Assets figures came in at $1.0 billion (Q1 2026), $225.3 million (Q4 2025), and $160.1 million (Q3 2025), per Business Quant data.